$OPRX News

What Trade Desk (TTD)'s Healthcare Inventory Integration With OptimizeRx Means For Shareholders

B. Riley Securities Maintains Buy on OptimizeRx, Raises Price Target to $11

Will OPRX's OpenPath Deal Help TTD Capture More Healthcare Ad Dollars?

OptimizeRx Partners With The Trade Desk To Widen Its Healthcare Ad Network

OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath

OptimizeRx: Gross Margin Gains And Improved Long-Term Outlook

OptimizeRx Expands Natural Language Audience Builder to Unify HCP and DTC Audience Intelligence

OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference

OptimizeRx (OPRX) Q2 2026 Earnings Call Transcript

Citizens Maintains Market Outperform on OptimizeRx, Raises Price Target to $11

OptimizeRx Corporation Q2 2026 Earnings Call Summary

OptimizeRx Corp (OPRX) (Q2 2026) Earnings Call Highlights: Navigating Revenue Headwinds with ...

OptimizeRx Q2 Earnings Call Highlights

OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth

OptimizeRx Reports Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance

OptimizeRx Corporation (OPRX) Q2 2026 Earnings Call Transcript

OptimizeRx Affirms FY2026 Sales Guidance of $95.000M-$100.000M vs $97.427M Est

OptimizeRx Q2 Adj. EPS $0.16 Beats $0.12 Estimate, Sales $20.504M Beat $20.204M Estimate

OptimizeRx Sets Second Quarter 2026 Conference Call for August 12, 2026, at 4:30 p.m. ET

OptimizeRx Appoints Veteran Point of Care Marketing Leader Sarah Bast as Chief Marketing Officer